Terms: = Ovarian cancer AND WHSC1, 7468, O96028, WHS, TRX5, REIIBP, NSD2, MMSET, MGC176638, KIAA1090, FLJ23286
10 results:
1. Somatic tumor mutations in moderate risk cancer genes: Targets for germline confirmatory testing.
Llorin H; Graf M; Chun N; Ford J
Cancer Genet; 2022 Nov; 268-269():22-27. PubMed ID: 36116289
[TBL] [Abstract] [Full Text] [Related]
2. The histone methyltransferase whsc1 is regulated by EZH2 and is important for ovarian clear cell carcinoma cell proliferation.
Kojima M; Sone K; Oda K; Hamamoto R; Kaneko S; Oki S; Kukita A; Machino H; Honjoh H; Kawata Y; Kashiyama T; Asada K; Tanikawa M; Mori-Uchino M; Tsuruga T; Nagasaka K; Matsumoto Y; Wada-Hiraike O; Osuga Y; Fujii T
BMC Cancer; 2019 May; 19(1):455. PubMed ID: 31092221
[TBL] [Abstract] [Full Text] [Related]
3. Migraine and invasive epithelial ovarian cancer risk in the Nurses' Health Study II and the Women's Health Study.
Rice MS; Rist PM; Winter AC; Kurth T; Tworoger SS
Int J Cancer; 2018 Feb; 142(3):534-539. PubMed ID: 28929486
[TBL] [Abstract] [Full Text] [Related]
4. E2F2 induces MCM4, CCNE2 and whsc1 upregulation in ovarian cancer and predicts poor overall survival.
Xie L; Li T; Yang LH
Eur Rev Med Pharmacol Sci; 2017 May; 21(9):2150-2156. PubMed ID: 28537669
[TBL] [Abstract] [Full Text] [Related]
5. A prospective study of circulating C-reactive protein, interleukin-6, and tumor necrosis factor α receptor 2 levels and risk of ovarian cancer.
Poole EM; Lee IM; Ridker PM; Buring JE; Hankinson SE; Tworoger SS
Am J Epidemiol; 2013 Oct; 178(8):1256-64. PubMed ID: 23966559
[TBL] [Abstract] [Full Text] [Related]
6. Overexpression of multiple myeloma SET domain (mmset) is associated with advanced tumor aggressiveness and poor prognosis in serous ovarian carcinoma.
Yang S; Zhang Y; Meng F; Liu Y; Xia B; Xiao M; Xu Y; Ning X; Li H; Lou G
Biomarkers; 2013 May; 18(3):257-63. PubMed ID: 23566000
[TBL] [Abstract] [Full Text] [Related]
7. Genetic polymorphisms of the GNRH1 and GNRHR genes and risk of breast cancer in the National cancer Institute Breast and Prostate cancer Cohort Consortium (BPC3).
Canzian F; Kaaks R; Cox DG; Henderson KD; Henderson BE; Berg C; Bingham S; Boeing H; Buring J; Calle EE; Chanock S; Clavel-Chapelon F; Dossus L; Feigelson HS; Haiman CA; Hankinson SE; Hoover R; Hunter DJ; Isaacs C; Lenner P; Lund E; Overvad K; Palli D; Pearce CL; Quiros JR; Riboli E; Stram DO; Thomas G; Thun MJ; Trichopoulos D; van Gils CH; Ziegler RG
BMC Cancer; 2009 Jul; 9():257. PubMed ID: 19640273
[TBL] [Abstract] [Full Text] [Related]
8. Plasma androgen concentrations and risk of incident ovarian cancer.
Tworoger SS; Lee IM; Buring JE; Hankinson SE
Am J Epidemiol; 2008 Jan; 167(2):211-8. PubMed ID: 17982156
[TBL] [Abstract] [Full Text] [Related]
9. Insulin-like growth factors and ovarian cancer risk: a nested case-control study in three cohorts.
Tworoger SS; Lee IM; Buring JE; Pollak MN; Hankinson SE
Cancer Epidemiol Biomarkers Prev; 2007 Aug; 16(8):1691-5. PubMed ID: 17684148
[TBL] [Abstract] [Full Text] [Related]
10. Plasma 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D and risk of incident ovarian cancer.
Tworoger SS; Lee IM; Buring JE; Rosner B; Hollis BW; Hankinson SE
Cancer Epidemiol Biomarkers Prev; 2007 Apr; 16(4):783-8. PubMed ID: 17416771
[TBL] [Abstract] [Full Text] [Related]
